Crossmark

Correction: Clinical features of patients with hepatocellular carcinoma treated with radiofrequency ablation therapy: developing a simple score to determine the need for immune-adjuvant therapy

Crossref DOI link: https://doi.org/10.1007/s12328-024-01996-x

Published Online: 2024-07-09

Published Print: 2024-10

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Tada, Fujimasa

Hiraoka, Atsushi https://orcid.org/0000-0003-1989-0480
Nakatani, Kosuke

Matsuoka, Kana

Fukumoto, Mai

Matsuda, Takuya

Yanagihara, Emi

Saneto, Hironobu

Murakami, Taisei

Onishi, Kei

Izumoto, Hirofumi

Kitahata, Shogo

Kanemitsu-Okada, Kozue

Kawamura, Tomoe

Kuroda, Taira

Hanaoka, Jun

Watanabe, Jota

Ohtani, Hiromi

Yoshida, Osamu

Hirooka, Masashi

Miyata, Hideki

Tsubouchi, Eiji

Abe, Masanori

Matsuura, Bunzo

Ninomiya, Tomoyuki

Hiasa, Yoichi
License Information

Text and Data Mining valid from 2024-07-09

Version of Record valid from 2024-07-09
More Information

Article History

First Online: 9 July 2024

Free to read: This content has been made available to all.

Document is current

Any future updates will be listed below